Atea Pharmaceuticals Inc (AVIR) — Defensive Interval Ratio
Atea Pharmaceuticals Inc (AVIR) has a Defensive Interval Ratio of 1933 days as of March 2026. Defensive assets of $176.69 Million (cash $-, short-term investments $176.69 Million, receivables $-) cover 1933 days of daily cash needs of $91.42K/day. See Atea Pharmaceuticals Inc (AVIR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Atea Pharmaceuticals Inc Defensive Interval Ratio (2020–2025)
This chart shows how Atea Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 1933 days, meaning defensive assets of $176.69 Million can fund 1933 days of operations without new revenue. See net asset quality index of Atea Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Atea Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Atea Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Atea Pharmaceuticals Inc (AVIR) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1891 days | $206.12 Million | $109.00K/day | $- | $206.12 Million | ▼ -5761 days |
| 2024 | 7652 days | $390.02 Million | $50.97K/day | $- | $390.02 Million | ▲ +2756 days |
| 2023 | 4896 days | $434.28 Million | $88.70K/day | $- | $434.28 Million | ▼ -4156 days |
| 2022 | 9052 days | $458.25 Million | $50.62K/day | $- | $458.25 Million | ▲ +9052 days |
| 2021 | 0 days | $0.00 | $155.84K/day | $- | $0.00 | ▼ -7 days |
| 2020 | 7 days | $5.82 Million | $865.19K/day | $- | $- | — |